Praxis Precision Medicines to Present at Upcoming Investor Conferences
May 14, 2021 09:00 ET
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference
March 08, 2021 08:30 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...
TLC to Present at Upcoming Virtual Investor Conferences
March 02, 2021 04:00 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 02, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
Misonix to Participate in Upcoming March Investor Conferences
March 01, 2021 08:07 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
Conformis, Inc. to Participate in Upcoming Investor Conferences
February 25, 2021 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
aTyr Pharma to Present at March Investor Conferences
February 25, 2021 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
February 12, 2021 08:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Conformis, Inc. Announces Proposed Public Offering of Common Stock
February 11, 2021 16:01 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
Los Alamos History Museum Provides Immersive Experience - Virtually and In-Person
October 29, 2020 17:00 ET
|
Los Alamos
Los Alamos, NM, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Los Alamos, New Mexico—where discoveries are made—is well known for its storied past, dating back to a series of volcanic eruptions 1.6 million...
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
October 28, 2020 18:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...